The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Landmark Analysis at the 25-Year Landmark Point
Abstract
This statistical primer presents the landmark analysis method, exploring its appropriate use and interpretation while recognizing its limitations. This observational method is used for comparing time-to-event outcome between groups determined during study follow-up. The goal of the landmark method is to estimate in an unbiased way the time-to-event probabilities in each group conditional on the group membership of patients at a specific time point, the landmark time. The need that led to its development, the impact of the method, and its pros and cons, along with available alternative approaches, are presented. Simulations explore its performance, using realistic parameters from a recent cardiovascular study. As long as the limitations of the method are recognized and the interpretation of its results clearly reflect their “conditional” nature, landmark analysis, 25 years from its introduction, can still be of value.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Analysis of survival by tumor response.
Anderson, J. R., Cain, K. C., & Gelber, R. D. (1983) · Journal of Clinical Oncology · doi:10.1200/jco.1983.1.11.710 · Cited by 1,107
Analysis of survival by tumor response.
Anderson, J. R., & Davis, R. B. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.1.115 · Cited by 1,000
Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent Implantation
Eisenstein, E. L., Anstrom, K. J., Kong, D. F., Shaw, L. K., Tuttle, R. H., Mark, D. B., Kramer, J. M., Harrington, R. A., Matchar, D. B., Kandzari, D. E., et al. (2007) · JAMA · doi:10.1001/jama.297.2.joc60179 · Cited by 870
Mantel, N., & Byar, D. P. (1974) · Journal of the American Statistical Association · doi:10.1080/01621459.1974.10480131 · Cited by 445
Moreton, P., Kennedy, B., Lucas, G., Leach, M., Rassam, S. M. B., Haynes, A., Tighe, J., Oscier, D., Fegan, C., Rawstron, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.021 · Cited by 419
Simon, R., & Makuch, R. W. (1984) · Statistics in Medicine · doi:10.1002/sim.4780030106 · Cited by 391
Food and Drug Administration requirements for approval of new anticancer drugs.
Johnson, J. R., & Temple, R. (1985) · PubMed · Cited by 298
Illustrating the Impact of a Time-Varying Covariate With an Extended Kaplan-Meier Estimator
Snapinn, S. M., Jiang, Q., & Iglewicz, B. (2005) · The American Statistician · doi:10.1198/000313005x70371 · Cited by 241
Analysis of Survival by Tumor Response and Other Comparisons of Time-to-Event by Outcome Variables
Anderson, J. R., Cain, K. C., & Gelber, R. D. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.1000 · Cited by 228
Late Coronary Stent Thrombosis
Windecker, S., & Meier, B. (2007) · Circulation · doi:10.1161/circulationaha.106.683995 · Cited by 226
(1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.5.960 · Cited by 194
Piedbois, P., Buyse, M. E., Blijham, G. H., et al. (1994) · Journal of Clinical Oncology · Cited by 191
Does Cardiac Transplantation Prolong Life? A Reassessment
Gail, M. H. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-5-815 · Cited by 137
ON THE RELATIONSHIP BETWEEN RESPONSE TO TREATMENT AND SURVIVAL TIME
Buyse, M. E., & Piedbois, P. (1996) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19961230)15:24<2797::aid-sim290>3.0.co;2-v · Cited by 133
Methodologic guidelines for reports of clinical trials.
Simon, R. M., & Wittes, R. E. (1985) · PubMed · Cited by 133
Outcomes Following Coronary Stenting in the Era of Bare-Metal vs the Era of Drug-Eluting Stents
Malenka, D. J., Kaplan, A. V., Lucas, F. L., Sharp, S. M., & Skinner, J. S. (2008) · JAMA · doi:10.1001/jama.299.24.2868 · Cited by 110
Chan, P. S., Nallamothu, B. K., Spertus, J. A., Masoudi, F. A., Bartone, C. L., Kereiakes, D. J., & Chow, T. (2009) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.807123 · Cited by 94
Cardiac Transplantation in Man
CLARK, D. A., Stinson, E. B., Griepp, R. B., Schroeder, J. S., Shumway, N. E., & Harrison, D. C. (1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-75-1-15 · Cited by 63
Methodologic Guidelines for Reports of Clinical Trials
&NA; (1986) · American Journal of Clinical Oncology · doi:10.1097/00000421-198606000-00019 · Cited by 55
Tricoci, P., Lokhnygina, Y. V., Berdan, L. G., Steinhubl, S. R., Gulba, D. C., White, H. D., Kleiman, N. S., Aylward, P. E., Langer, A., Califf, R. M., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.690081 · Cited by 53
Studies of Drug-Eluting Stents
Mauri, L., & Normand, S. T. (2008) · Circulation · doi:10.1161/circulationaha.108.770164 · Cited by 16
Cited by
Nienaber, C. A., Kische, S., Rousseau, H., Eggebrecht, H., Rehders, T. C., Kundt, G., Glass, A., Scheinert, D., Czerny, M., Kleinfeldt, T., et al. (2013) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.113.000463 · Cited by 1,110
Connolly, S. J., Eikelboom, J. W., Bosch, J., Dagenais, G., Dyal, L., Lanas, F., Metsarinne, K., O'Donnell, M., Dans, A. L., Ha, J.-W., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32458-3 · Cited by 754
Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT
Van Gelder, I. C., Healey, J. S., Crijns, H. J. G. M., Wang, J., Hohnloser, S. H., Gold, M. R., Capucci, A., Lau, C.-P., Morillo, C. A., Hobbelt, A. H., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx042 · Cited by 599
Challenges of Guarantee-Time Bias
Giobbie-Hurder, A., Gelber, R. D., & Regan, M. M. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.5283 · Cited by 458
Radvanyi, L. G., Bernatchez, C., Zhang, M., Fox, P. S., Miller, P., Chacon, J., Wu, R., Lizee, G., Mahoney, S., Alvarado, G., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1177 · Cited by 427
Metadata
- Authors
- Dafni, U.
- Venue
- Circulation: Cardiovascular Quality and Outcomes
- Published
- 2011-05
- Volume
- 4
- Issue
- 3
- Pages
- 363-371
- ISSN
- 1941-7705 (ISSN-L)
- 1941-7713
- OpenAlex
- W2138740885
- Cited by
- 569
- References
- 23
- FWCI
- 8.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.